N,N'-Desethylene Levofloxacin Hydrochloride

N,N'-Desethylene Levofloxacin Hydrochloride Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

Yellow Solid

Verwenden

Levofloxacin (L360000) impurity. A photodegradation product of Levofloxacin (L360000) in aqueous solution.

N,N'-Desethylene Levofloxacin Hydrochloride Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

N,N'-Desethylene Levofloxacin Hydrochloride Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Hubei Jusheng Technology Co.,Ltd.	18871490254	linda@hubeijusheng.com	CHINA	28172	58
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14332	58
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19553	58
CR Corporation Limited	+8613062833949	fred.wen@crcorporation.cn	China	8647	58
sgtlifesciences pvt ltd	+8617013299288	dj@sgtlifesciences.com	China	12373	58
China National Standard Pharmaceutical Corporation Limited	+8615391658522	overseasales@yongstandards.com	China	11922	58
LEAPCHEM CO., LTD.	+86-852-30606658	market18@leapchem.com	China	43340	58
Amadis Chemical Company Limited	571-89925085	sales@amadischem.com	China	131957	58
QUALITY CONTROL SOLUTIONS LTD.	0755-66853366; 13670046396	ORDERS@QCSRM.COM	China	24326	58
J & K SCIENTIFIC LTD.	010-82848833 400-666-7788	jkinfo@jkchemical.com	China	96815	76

---

• N,N'-Desethylene Levofloxacin Hydrochloride
• (S)-9-Fluoro-2,3-dihydro-3-Methyl-10-[[2-(MethylaMino)ethyl]aMino]-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Hydrochloride
• (S)-9-fluoro-3-methyl-10- ((2-(methylamino)ethyl)amino) -7-oxo-2,3-dihydro-7H-[1,4]oxazino [2,3,4-ij]quinoline-6-carboxylic acid
• N,N'-Desethylene Levofloxacin 1
• Levofloxacin-002-S
• (S)-9-Fluoro-2,3-dihydro-3-Methyl-10-[[2-(MethylaMino)ethyl]aMino]-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
• Levofloacin Impurity
• Levofloxacin Impurity 5 Monomer
• UNII-97IR3584AJ
• (S)-9-fluoro-3-methyl-10
• Levofloxacin impurity 4/Levofloxacin EP Impurity G/N,N'-Desethylene Levofloxacin
• Levofloacin Impurity 1
• Levofloxacin USP Impurity C
• 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-[[2-(methylamino)ethyl]amino]-7-oxo-, (S)- (9CI)
• Levofloxacin EP Impurity G (N,N'-Desethylene Levofloxacin)
• Levofloxacin ImpurityABCDE
• Levofloxacin diamine derivatives
• Levofloxacin USP Impurity B
• Levofloxacin Impurity 5 Monomer (Levofloxacin EP Impurity G Monomer)
• (S)-9-Fluoro-3-methyl-10-((2-(methylamino)ethyl)amino)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid (Levofloxacin Impurity)
• N,N'-Desethylene Levofloxacin Hydrochloride
• Levofloxacin EP Impurity G(Levofloxacin USP Related Compound E)
• N,N’-Desethylene Levofloxacin
• Levofloxacin EP Impurity G (N,N'-Desethylene Levofloxacin)
• Levofloxacin EP Impurity G (Levofloxacin USP Related Compound E (Free Form), N,N'-Desethylene Levofloxacin)
• Levofloxacin EP Impurity G (N,N'-Desethylene Levofloxacin) Tris-Trifluoroacetate
• 151250-76-9
• C16H19ClFN3O4
• Chiral Reagents
• Heterocycles
• Impurities
• Intermediates & Fine Chemicals
• Pharmaceuticals